KPV
Also known as: Lys-Pro-Val, Alpha-MSH fragment
Primary recreational use: Immune modulation and gut health
What is KPV?
KPV is a therapeutic tripeptide derived from the C-terminal fragment of alpha-melanocyte stimulating hormone (α-MSH). It exhibits potent anti-inflammatory and antimicrobial properties without the pigmentation effects of full α-MSH. KPV is being researched for potential use in inflammatory bowel diseases, skin conditions, and immune modulation. Currently, it is not approved by the FDA and remains in preclinical testing, with primary concerns involving a lack of human safety data.
Primary Benefits
Reduces inflammation. Supports gut health. Antimicrobial effects.
How It Works
KPV retains the anti-inflammatory properties of α-MSH by inhibiting inflammatory pathways such as NF-κB, reducing pro-inflammatory cytokines. It penetrates cells to interact directly with inflammatory signaling pathways, providing potent anti-inflammatory and antimicrobial effects.
Safety Tips
Precautions reported in community discussions and literature. This is not a complete list.
- 1.DON'T start with a high dose - begin with the lowest effective dose to assess tolerance.
- 2.AVOID using if you have a history of cancer due to contraindications.
- 3.DON'T inject without proper sterile technique to prevent infection.
- 4.NEVER use if pregnant or breastfeeding without consulting a healthcare provider.
- 5.DON'T use non-pharmaceutical-grade sources due to contamination risks.
- 6.AVOID combining with unknown substances due to potential interactions.
- 7.NEVER use unapproved or research-grade peptides for consumption.
- 8.DON'T store at improper temperatures to avoid degradation.
- 9.AVOID continuous use without breaks to assess baseline inflammation.
- 10.DON'T share needles or vials to prevent transmission of infections.
Use Contexts
Different purposes have different protocols, dosing, and considerations
Inflammatory bowel disease
limited evidenceKPV is being researched for treatment of inflammatory bowel diseases due to its anti-inflammatory properties.
Evidence: Primarily supported by animal studies and preclinical research for inflammatory impact.
The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.
Timing: Morning
Notes: Use with caution in individuals with a cancer history, due to contraindications.
Community-Reported Protocols
Not recommendations: The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.
| Reported Goal | Reported Dose | Reported Frequency | Reported Route |
|---|---|---|---|
| General Anti-Inflammatory | 200-300mcg | Once daily | Subcutaneous injection |
Pharmacokinetics
Reported Side Effects
This is not a complete list. Other side effects may occur.
Common
Serious / Rare
- Contraindication with cancer history
Injection-Specific Warnings
- Risk of infection if sterile technique is not followed
Storage
Autoimmune support
limited evidenceKPV is explored for balancing overactive immune responses in autoimmune conditions.
Evidence: Exploratory studies suggest potential in modulating immune responses, but human data is lacking.
The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.
Timing: Flexible, as directed.
Notes: Dose adjustments might be necessary based on immune response.
Community-Reported Protocols
Not recommendations: The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.
| Reported Goal | Reported Dose | Reported Frequency | Reported Route |
|---|---|---|---|
| Autoimmune Support | 500mcg | Once daily | Subcutaneous injection |
Pharmacokinetics
Reported Side Effects
This is not a complete list. Other side effects may occur.
Common
Serious / Rare
- Contraindication with cancer history
Injection-Specific Warnings
- Risk of infection if sterile technique is not followed
Storage
Harm Reduction Information
Quality Concerns
- Research-grade peptides may have impurities
- Potential contamination in non-pharmaceutical sources
- Variable purity and potency in unregulated products
Safety Tips
- Use pharmaceutical-grade KPV when possible
- Strictly follow sterile injection practices
- Rotate injection sites to prevent irritation
- Start with lowest effective dose to assess tolerance
Warning Signs to Stop
- Severe allergic reactions
- New or changing skin lesions
- Persistent flu-like symptoms
Seek Medical Help Immediately If
- Severe injection site reactions
- Signs of anaphylaxis
Frequently Asked Questions
Common questions about KPV
How long until I see effects?
KPV typically shows initial anti-inflammatory effects within 3-7 days, with significant improvement in 2-4 weeks.
What time of day should I take it?
KPV can be administered at any time; however, morning doses are preferred for managing daytime inflammation.
How can I minimize side effects?
To minimize side effects with KPV, ensure proper dosage and use sterile techniques for injections.
Does tolerance develop?
There is limited evidence on tolerance development for KPV. Cycling use with breaks is recommended to prevent potential tolerance.
How should I store it?
Store KPV in a refrigerator at 2-8°C to maintain stability post-reconstitution.
Do I need to cycle it?
Cycling KPV with periods of use for 4-8 weeks followed by breaks is recommended to reassess inflammation levels.
Can I combine it with other peptides?
KPV can be combined with peptides like BPC-157 and TB-500 for enhanced anti-inflammatory effects.
Reported Combinations
Compounds reported to be used alongside KPV in community discussions
BPC-157
Both offer synergistic anti-inflammatory effects for gut health.
TB-500
Synergistic in accelerating wound healing.
LL-37
Combined antimicrobial effects for gut health.
Reported Interactions
Interactions reported in literature and community discussions.
Concomitant use may increase risk of gastric irritation.
May potentiate immune suppression.
Possible additive hypotensive effects.
Reconstitution Calculator
100 units = 1 mL
Safety Tips
- Always consult a licensed medical professional for dosing and reconstitution instructions.
- Always double check your units. Mixing up mg and mcg can be very dangerous.
- Make sure to select your syringe type. U-100 and U-50 syringes have different units.
- Ensure you're not adding more BAC than your vial can hold. Most vials have maximum capacities listed.
This calculator is for informational and educational purposes only. It does not provide medical advice, dosing recommendations, or safety determinations. Reference ranges shown are compiled from publicly available sources and are not a substitute for guidance from a licensed healthcare professional.
Legal Status by Region
Regulatory status varies by country
USA
Research use only
UK
Research use only
EU
Research use only
Australia
Research use only
Canada
Research use only
Explore More Research
Browse our database of peptide research information compiled from published literature and community sources.
Citations
Last updated: October 4, 2023